UOC
BLUE

UBS O'Connor’s bluebird bio BLUE Stock Holding History

UBS O'Connor’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,081
Closed -$855K – 336
2020
Q2 		$855K Buy
+1,081
New +$815K 0.02% 293
2015
Q3 		– Sell
-1,216
Closed -$2.65M – 522
2015
Q2 		$2.65M Buy
+1,216
New +$2.48M 0.05% 309

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

UBS O'Connor's BLUE Position: Q3 2020 in Review

UBS O'Connor sold out of bluebird bio (BLUE) in Q3 2020, closing a stake of 1,081 shares — an estimated $855K sold.

UBS O'Connor first reported a position in BLUE in Q2 2015 and held it in 2 quarters. The position peaked at $2.65M in Q2 2015. 275 funds tracked by Wall St. Rank hold BLUE as of Q3 2020.

  • UBS O'Connor reported no remaining bluebird bio position as of Q3 2020 after selling out during the quarter.
  • UBS O'Connor sold 1,081 bluebird bio shares in Q3 2020, an estimated $855K.
  • UBS O'Connor first reported a position in bluebird bio in Q2 2015 and held it in 2 quarters.
  • UBS O'Connor's bluebird bio position peaked at $2.65M in Q2 2015.
  • 275 funds tracked by Wall St. Rank held bluebird bio as of Q3 2020.

Based on UBS O'Connor's 13F filing for Q3 2020, filed 12 Nov 2020.